Диссертация (1140107), страница 22
Текст из файла (страница 22)
9. – С. 530-540. doi: 10.17235/reed.2016.4261/201681) Dickson R. P. et al. Bacterial topography of the healthy human lower respiratorytract //MBio. – 2017. – Т. 8. – №. 1. – С. E02287-16. doi: 10.1128/mBio.02287-16.82) Dobbin K. K., Simon R. M. Optimally splitting cases for training and testing highdimensional classifiers //BMC medical genomics.
– 2011. – Т. 4. – №. 1. – С. 31.doi:10.1186/1755-8794-4-31.83) Domingo M. C. et al. Cloacibacillus sp., a potential human pathogen associatedwith bacteremia in Quebec and New Brunswick //Journal of clinical microbiology. –1352015. – Т. 53. – №. 10. – С. 3380-3383. doi:10.1128/JCM.01137-15.84) Dong T. et al. Alteration of stomach microbiota compositions in the progression ofgastritis induces nitric oxide in gastric cell //Experimental and therapeutic medicine. –2017. – Т.
13. – №. 6. – С. 2793-2800. doi:10.3892/etm.2017.437385) Dreno B. et al. Skin microbiome and acne vulgaris: Staphylococcus, a new actor inacne //Experimental dermatology. – 2017. – Т. 26. – №. 9. – С. 798-803. doi:10.1111/exd.1329686) Du Y. et al. Histone deacetylase 6 regulates cytotoxic α-synuclein accumulationthrough induction of the heat shock response //Neurobiology of aging. – 2014. – Т.
35.– №. 10. – С. 2316-2328. doi: 10.1016/j.neurobiolaging.2014.04.02987) Dzamko N. et al. Toll-like receptor 2 is increased in neurons in Parkinson’s diseasebrain and may contribute to alpha-synuclein pathology //Acta neuropathologica. – 2017.– Т. 133. – №. 2. – С. 303-319. doi:10.1007/s00401-016-1648-8.88) Edgar R. C. Search and clustering orders of magnitude faster than BLAST//Bioinformatics.–2010.–Т.26.–№.19.–С.2460-2461.doi:10.1093/bioinformatics/btq46189) Ellis M.
L. et al. Probiotic properties of Oxalobacter formigenes: an in vitroexamination //Archives of microbiology. – 2016. – Т. 198. – №. 10. – С. 1019-1026.doi:10.1007/s00203-016-1272-y90) Faith D. P. Conservation evaluation and phylogenetic diversity //Biologicalconservation. – 1992a. – Т. 61. – №. 1. – С.
1-10.91) Faith D. P. Systematics and conservation: on predicting the feature diversity ofsubsets of taxa //Cladistics. – 1992b. – Т. 8. – №. 4. – С. 361-373.92) Faust K. et al. Microbial co-occurrence relationships in the human microbiome//PLoS computational biology. – 2012. – Т. 8. – №. 7. – С.
e1002606. doi:10.1371/journal.pcbi.100260693) Fearnley J. M., Lees A. J. Ageing and Parkinson's disease: substantia nigra regionalselectivity //Brain. – 1991. – Т. 114. – №. 5. – С. 2283-2301. doi:10.1093/brain/114.5.228394) Fernando M. R. et al. Butyrate enhances antibacterial effects while suppressing136other features of alternative activation in IL-4-induced macrophages //American Journalof Physiology-Gastrointestinal and Liver Physiology. – 2016.
– Т. 310. – №. 10. – С.G822-G831. doi: 10.1152/ajpgi.00440.201595) Festi D. et al. Gut microbiota and metabolic syndrome //World journal ofgastroenterology: WJG. – 2014. – Т. 20. – №. 43. – С. 16079. doi:10.3748/wjg.v20.i43.16079.96) Figliuolo V.
R. et al. Sulfate-reducing bacteria stimulate gut immune responses andcontribute to inflammation in experimental colitis //Life sciences. – 2017. – Т. 189. – С.29-38. doi: 10.1016/j.lfs.2017.09.014.97) Fischbach M. A., Segre J. A. Signaling in host-associated microbial communities//Cell. – 2016. – Т. 164. – №. 6. – С. 1288-1300. doi: 10.1016/j.cell.2016.02.037.98) Forsyth C. B. et al. Increased intestinal permeability correlates with sigmoid mucosaalpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease//PloS one.
– 2011. – Т. 6. – №. 12. – С. e28032. doi:10.1371/journal.pone.0028032.99) Forsythe P., Kunze W. A. Voices from within: gut microbes and the CNS //Cellularand molecular life sciences. – 2013. – Т. 70. – №. 1. – С. 55-69. doi: 10.1007/s00018012-1028-z100) Fouhy F. et al. A pilot study demonstrating the altered gut microbiota functionalityin stable adults with Cystic Fibrosis //Scientific Reports. – 2017. – Т. 7.
– №. 1. – С.6685. doi: 10.1038/s41598-017-06880-y101) Frank D. N. et al. The human nasal microbiota and Staphylococcus aureus carriage//PloS one. – 2010. – Т. 5. – №. 5. – С. e10598. doi: 10.1371/journal.pone.0010598.102) Fukuda K. et al. Molecular approaches to studying microbial communities:targeting the 16S ribosomal RNA gene //Journal of UOEH. – 2016. – Т.
38. – №. 3. – С.223-232. doi: 10.7888/juoeh.38.223103) Fukuda S. et al. Bifidobacteria can protect from enteropathogenic infectionthrough production of acetate //Nature. – 2011. – Т. 469. – №. 7331. – С. 543. doi:10.1038/nature09646104) Gaig C., Tolosa E. When does Parkinson's disease begin? //Movement Disorders. –2009.
– Т. 24. – №. S2. – С. 656-664. doi:10.1002/mds.22672137105) Ganji L. et al. Dysbiosis of fecal microbiota and high frequency of Citrobacter,Klebsiella spp., and Actinomycetes in patients with irritable bowel syndrome andgastroenteritis //Gastroenterology and Hepatology from bed to bench. – 2016. – Т. 9. –№. 4. – С.
325.106) Gill S. R. et al. Metagenomic analysis of the human distal gut microbiome//science. – 2006. – Т. 312. – №. 5778. – С. 1355-1359. doi:10.1126/science.1124234107) Goetze O. et al. Impaired gastric emptying of a solid test meal in patients withParkinson's disease using 13C-sodium octanoate breath test //Neuroscience letters. –2005. – Т. 375. – №.
3. – С. 170-173. doi:10.1016/j.neulet.2004.11.007108) Goldstein D. S. et al. Cardiac sympathetic denervation in Parkinson disease//Annals of internal medicine. – 2000. – Т. 133. – №. 5. – С. 338-347.109) Goodrich J. K. et al. Human genetics shape the gut microbiome //Cell. – 2014. – Т.159.
– №. 4. – С. 789-799. doi:10.1016/j.cell.2014.09.053110) Goyal D. K., Miyan J. A. Neuro-immune abnormalities in autism and theirrelationship with the environment: a variable insult model for autism //Frontiers inendocrinology. – 2014. – Т. 5. – С. 29. doi: 10.3389/fendo.2014.00029111) Guo J. et al. Microbial community analysis with ribosomal gene fragments fromshotgun metagenomes //Applied and environmental microbiology. – 2016. – Т. 82. – №.1. – С. 157-166.
doi:10.1128/AEM.02772-15112) Gupta S., Prasad G. V. R. K., Mukhopadhaya A. Vibrio cholerae porin OmpUinduces caspase-independent programmed cell death upon translocation to the host cellmitochondria //Journal of Biological Chemistry. – 2015. – Т. 290. – №. 52. – С. 3105131068. doi: 10.1074/jbc.M115.670182113) Gupta V. K., Paul S., Dutta C.
Geography, ethnicity or subsistence-specificvariations in human microbiome composition and diversity //Frontiers in microbiology.– 2017. – Т. 8. – С. 1162. doi:10.3389/fmicb.2017.01162.114) Hague K. et al. The distribution of Lewy bodies in pure autonomic failure: autopsyfindings and review of the literature //Acta neuropathologica.
– 1997. – Т. 94. – №. 2. –С. 192-196.115) Hall N. Advanced sequencing technologies and their wider impact in microbiology138//Journal of Experimental Biology. – 2007. – Т. 210. – №. 9. – С. 1518-1525. doi:10.1242/jeb.001370116) Hamady M., Knight R. Microbial community profiling for human microbiomeprojects: Tools, techniques, and challenges //Genome research. – 2009. – Т. 19.
– №. 7.– С. 1141-1152. doi: 10.1101/gr.085464.108117) Hamer H. M. et al. The role of butyrate on colonic function //Alimentarypharmacology & therapeutics. – 2008. – Т. 27. – №. 2. – С. 104-119.doi:10.1111/j.1365-2036.2007.03562.x118) Hand D. J., Yu K. Idiot's Bayes—not so stupid after all? //International statisticalreview. – 2001. – Т. 69. – №.
3. – С. 385-398. doi: 10.1111/j.17515823.2001.tb00465.x119) Handelsman J. et al. Molecular biological access to the chemistry of unknown soilmicrobes: a new frontier for natural products //Chemistry & biology. – 1998. – Т. 5. –№. 10. – С. R245-R249. doi: 10.1016/S1074-5521(98)90108-9120) Harrison I. F., Dexter D. T. Epigenetic targeting of histone deacetylase: therapeuticpotential in Parkinson's disease? //Pharmacology & therapeutics. – 2013. – Т.
140. – №.1. – С. 34-52. doi: 10.1016/j.pharmthera.2013.05.010121) Hasegawa S. et al. Intestinal dysbiosis and lowered serum lipopolysaccharidebinding protein in Parkinson’s disease //PLoS One. – 2015. – Т. 10. – №. 11. – С.e0142164. doi: 10.1371/journal.pone.0142164122) Hawkes C. H., Del Tredici K., Braak H. A timeline for Parkinson's disease//Parkinsonism & related disorders. – 2010. – Т.
16. – №. 2. – С. 79-84. doi:10.1016/j.parkreldis.2009.08.007.123) Heckman M. G. et al. Parkinson's disease susceptibility variants and severity ofLewy body pathology //Parkinsonism & related disorders. – 2017. – Т. 44. – С. 79-84.doi: 10.1016/j.parkreldis.2017.09.009124) Hegarty S.
V., Sullivan A. M., O'Keeffe G. W. The Epigenome as a therapeutictarget for Parkinson's disease //Neural regeneration research. – 2016. – Т. 11. – №. 11. –С. 1735. doi:10.4103/1673-5374.194803.125) Heijtz R. D. et al. Normal gut microbiota modulates brain development and139behavior //Proceedings of the National Academy of Sciences. – 2011. – Т. 108. – №. 7.– С. 3047-3052. doi: 10.1073/pnas.1010529108.126) Heintz‐Buschart A.
et al. The nasal and gut microbiome in Parkinson's disease andidiopathic rapid eye movement sleep behavior disorder //Movement Disorders. – 2018.– Т. 33. – №. 1. – С. 88-98. doi: 10.1002/mds.27105127) Hill‐Burns E. M. et al. Parkinson's disease and Parkinson's disease medicationshave distinct signatures of the gut microbiome //Movement disorders. – 2017. – Т.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
